Evidence map›Paper›PMID 39036092›Full record

ArticleBioengineering & translational medicine2024

Trafficking through the blood-brain barrier is directed by core and outer surface components of layer-by-layer nanoparticles.

Nicholas G Lamson, Andrew J Pickering, Jeffrey Wyckoff, Priya Ganesh, Elizabeth A Calle, Joelle P Straehla, Paula T Hammond

Abstract read
In one paragraph

Article in Bioengineering & translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicholas G LamsonKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge Massachusetts USA.ORCID https://orcid.org/0000-0002-6961-1577
Andrew J PickeringKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge Massachusetts USA.
Jeffrey WyckoffKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge Massachusetts USA.
Priya GaneshKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge Massachusetts USA.
Elizabeth A CalleKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge Massachusetts USA.
Joelle P StraehlaKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge Massachusetts USA.
Paula T HammondKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology Cambridge Massachusetts USA.ORCID https://orcid.org/0000-0002-9835-192X

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Kristin A Knouse · 1985 to 2026
$93.9M
Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical EducationK12HL141953 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHAIKOF, ELLIOT, CUMMINGS, RICHARD D · 2018 to 2022
$4.8M
NCI NIH HHS P30 CA014051NHLBI NIH HHS K12 HL141953
6 · The paper itself

Abstract

Drug-carrying nanoparticles are a promising strategy to deliver therapeutics into the brain, but their translation requires better characterization of interactions between nanomaterials and endothelial cells of the blood-brain barrier (BBB). Here, we use a library of 18 layer-by-layer electrostatically assembled nanoparticles (NPs) to independently assess the impact of NP core and surface materials on in vitro uptake, transport, and intracellular trafficking in brain endothelial cells. We demonstrate that NP core stiffness determines the magnitude of transport, while surface chemistry directs intracellular trafficking. Finally, we demonstrate that these factors similarly dictate in vivo BBB transport using intravital imaging through cranial windows in mice. We identify that hyaluronic acid surface chemistry increases transport across the BBB in vivo, and flow conditions are necessary to replicate this finding in vitro. Taken together, these findings highlight the importance of assay geometry, cell biology, and fluid flow in developing nanocarriers for delivery to the brain.

Indexed as

blood–brain barrierdrug deliveryintracellular traffickingintravital imagingin vitro modelslayer‐by‐layernanoparticles

Identifiers

PMID39036092
PMCPMC11256136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.